(Q28276386)

1

0 references

S S Ahuja

2

0 references

E Gonzalez

3

0 references

S A Anderson

4

0 references

E N Santiago

5

0 references

K T Stephan

6

0 references

F E Craig

7

0 references

P O'Connell

8

0 references

V Tryon

9

0 references

R A Clark

10

0 references

M J Dolan

11

0 references

S K Ahuja

Identification of a major co-receptor for primary isolates of HIV-1

12

0 references

language of work or name

English

0 references

publication date

July 1998

0 references

published in

Nature Medicine

0 references

volume

4

0 references

issue

7

0 references

page(s)

786-93

0 references

cites work

1 reference

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 April 2017

1 reference

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 April 2017

1 reference

Coreceptors--Implications for HIV Pathogenesis and Therapy

21 April 2017

1 reference

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Co-receptors for HIV-1 entry

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

HIV-Infected Individuals With the CCR5Δ32/CCR5 Genotype Have Lower HIV RNA Levels and Higher CD4 Cell Counts in the Early Years of the Infection Than Do Patients With the Wild Type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

A new classification for HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Association between CCR5 genotype and the clinical course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

CCR2 Polymorphism and HIV Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

The role of genomics in studying genetic susceptibility to infectious disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

A Single Amino Acid Change Converts an Inhibitory Transcription Factor into an Activator

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1038%2FNM0798-786

7 January 2021